CLINICAL_TRIALS
trial_result
· 2020-02-21
Clinical Trial Update: Safety and Biological Activity of Vesatolimod in HIV-1 Infected, Virologically Suppressed Adults [Phase 1]
Summary
Phase 1 trial assessing safety and biological activity of vesatolimod in adults with HIV-1 infection who are virologically suppressed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Gilead Sciences | Conditions: HIV-1 Infection | Phase 1 | Status: COMPLETED | Results posted: 2020-02-21